| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |